C. FRANK BENNETT - 31 Aug 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Officer Level 14
Signature
By: Patrick R. O'Neil, attorney-in-fact For: C. Frank Bennett
Issuer symbol
IONS
Transactions as of
31 Aug 2023
Net transactions value
+$5,500
Form type
4
Filing time
05 Sep 2023, 16:59:22 UTC
Previous filing
02 Mar 2023
Next filing
29 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Other $5,500 +180 +0.26% $30.56 70,214 31 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2023. These shares may not be sold until February 29, 2024.